Integrative Chemoproteomics Reveals Anticancer Mechanisms of Silver(i) Targeting the Proteasome Regulatory Complex

Overview

Journal Chem Sci

Publisher Royal Society of Chemistry

Specialty Chemistry

Date 2024 Apr 5

PMID 38577372

Authors

Xiaojian Shao

Fangrong Xing

Yiwei Zhang

Chun-Nam Lok

Chi-Ming Che

Affiliations

Soon will be listed here.

Abstract

Silver compounds have favorable properties as promising anticancer drug candidates, such as low side effects, anti-inflammatory properties, and high potential to overcome drug resistance. However, the exact mechanism by which Ag(i) confers anticancer activity remains unclear, which hinders further development of anticancer applications of silver compounds. Here, we combine thermal proteome profiling, cysteine profiling, and ubiquitome profiling to study the molecular mechanisms of silver(i) complexes supported by non-toxic thiourea (TU) ligands. Through the formation of AgTU complexes, TU ligands deliver Ag ions to cancer cells and tumour xenografts to elicit inhibitory potency. Our chemical proteomics studies show that AgTU acts on the ubiquitin-proteasome system (UPS) and disrupts protein homeostasis, which has been identified as a main anticancer mechanism. Specifically, Ag ions are released from AgTU in the cellular environment, directly target the 19S proteasome regulatory complex, and may oxidize its cysteine residues, thereby inhibiting proteasomal activity and accumulating ubiquitinated proteins. After AgTU treatment, proteasome subunits are massively ubiquitinated and aberrantly aggregated, leading to impaired protein homeostasis and paraptotic death of cancer cells. This work reveals the unique anticancer mechanism of Ag(i) targeting the 19S proteasome regulatory complex and opens up new avenues for optimizing silver-based anticancer efficacy.

References

Franken H, Mathieson T, Childs D, Sweetman G, Werner T, Togel I . Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry. Nat Protoc. 2015; 10(10):1567-93. DOI: 10.1038/nprot.2015.101. View

Harrigan J, Jacq X, Martin N, Jackson S . Deubiquitylating enzymes and drug discovery: emerging opportunities. Nat Rev Drug Discov. 2017; 17(1):57-78. PMC: 7097658. DOI: 10.1038/nrd.2017.152. View

Fontana F, Raimondi M, Marzagalli M, Di Domizio A, Limonta P . The emerging role of paraptosis in tumor cell biology: Perspectives for cancer prevention and therapy with natural compounds. Biochim Biophys Acta Rev Cancer. 2020; 1873(2):188338. DOI: 10.1016/j.bbcan.2020.188338. View

Peng K, Zheng Y, Xia W, Mao Z . Organometallic anti-tumor agents: targeting from biomolecules to dynamic bioprocesses. Chem Soc Rev. 2023; 52(8):2790-2832. DOI: 10.1039/d2cs00757f. View

Qin L, Wang P, Guo Y, Chen C, Liu M . Self-Assembled Soft Nanomaterials Via Silver(I)-Coordination: Nanotube, Nanofiber, and Remarkably Enhanced Antibacterial Effect. Adv Sci (Weinh). 2016; 2(11):1500134. PMC: 5115345. DOI: 10.1002/advs.201500134. View

Xu Z, Zha X, Ji R, Zhao H, Zhou S . Green Biosynthesis of Silver Nanoparticles Using Aqueous Extracts of and Their Anti-Inflammatory Effects. ACS Appl Mater Interfaces. 2023; . DOI: 10.1021/acsami.2c22114. View

Wang X, Wang X, Jin S, Muhammad N, Guo Z . Stimuli-Responsive Therapeutic Metallodrugs. Chem Rev. 2018; 119(2):1138-1192. DOI: 10.1021/acs.chemrev.8b00209. View

Anchoori R, Karanam B, Peng S, Wang J, Jiang R, Tanno T . A bis-benzylidine piperidone targeting proteasome ubiquitin receptor RPN13/ADRM1 as a therapy for cancer. Cancer Cell. 2013; 24(6):791-805. PMC: 3881268. DOI: 10.1016/j.ccr.2013.11.001. View

Chen X, Yang Q, Chen J, Zhang P, Huang Q, Zhang X . Inhibition of Proteasomal Deubiquitinase by Silver Complex Induces Apoptosis in Non-Small Cell Lung Cancer Cells. Cell Physiol Biochem. 2018; 49(2):780-797. DOI: 10.1159/000493041. View

10.

Sun D, Wu R, Zheng J, Li P, Yu L . Polyubiquitin chain-induced p62 phase separation drives autophagic cargo segregation. Cell Res. 2018; 28(4):405-415. PMC: 5939046. DOI: 10.1038/s41422-018-0017-7. View

11.

Kemper E, Zhang Y, Dix M, Cravatt B . Global profiling of phosphorylation-dependent changes in cysteine reactivity. Nat Methods. 2022; 19(3):341-352. PMC: 8920781. DOI: 10.1038/s41592-022-01398-2. View

12.

Trader D, Simanski S, Kodadek T . A reversible and highly selective inhibitor of the proteasomal ubiquitin receptor rpn13 is toxic to multiple myeloma cells. J Am Chem Soc. 2015; 137(19):6312-9. PMC: 4455945. DOI: 10.1021/jacs.5b02069. View

13.

Yang F, Jia G, Guo J, Liu Y, Wang C . Quantitative Chemoproteomic Profiling with Data-Independent Acquisition-Based Mass Spectrometry. J Am Chem Soc. 2022; 144(2):901-911. DOI: 10.1021/jacs.1c11053. View

14.

Puchkova L, Broggini M, Polishchuk E, Ilyechova E, Polishchuk R . Silver Ions as a Tool for Understanding Different Aspects of Copper Metabolism. Nutrients. 2019; 11(6). PMC: 6627586. DOI: 10.3390/nu11061364. View

15.

Panacek D, Hochvaldova L, Bakandritsos A, Malina T, Langer M, Belza J . Silver Covalently Bound to Cyanographene Overcomes Bacterial Resistance to Silver Nanoparticles and Antibiotics. Adv Sci (Weinh). 2021; 8(12):2003090. PMC: 8224420. DOI: 10.1002/advs.202003090. View

16.

Lim Y, Tiemann K, Heo G, Wagers P, Rezenom Y, Zhang S . Preparation and in vitro antimicrobial activity of silver-bearing degradable polymeric nanoparticles of polyphosphoester-block-poly(L-lactide). ACS Nano. 2015; 9(2):1995-2008. PMC: 4455953. DOI: 10.1021/nn507046h. View

17.

Li W, He P, Huang Y, Li Y, Lu J, Li M . Selective autophagy of intracellular organelles: recent research advances. Theranostics. 2021; 11(1):222-256. PMC: 7681076. DOI: 10.7150/thno.49860. View

18.

Lee D, Kim I, Saha S, Choi K . Paraptosis in the anti-cancer arsenal of natural products. Pharmacol Ther. 2016; 162:120-33. DOI: 10.1016/j.pharmthera.2016.01.003. View

19.

Garzia A, Jafarnejad S, Meyer C, Chapat C, Gogakos T, Morozov P . The E3 ubiquitin ligase and RNA-binding protein ZNF598 orchestrates ribosome quality control of premature polyadenylated mRNAs. Nat Commun. 2017; 8:16056. PMC: 5504347. DOI: 10.1038/ncomms16056. View

20.

Hoeller D, Dikic I . How the proteasome is degraded. Proc Natl Acad Sci U S A. 2016; 113(47):13266-13268. PMC: 5127301. DOI: 10.1073/pnas.1616535113. View